Potentially lethal damage repair and its inhibitory effect of caffeine in two yolk sac tumor cell lines with different radiosensitivities

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 199-206

  Akimoto, Tetsuo ^a   Mitsuhashi, Norio ^a   Matsumoto, Hiroko ^a   Sakurai, Hideyuki ^a   Maebayashi, Katsuya ^a   Higuchi, Keiko ^a   Nozaki, Miwako ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Caffeine; Cell cycle; Potentially lethal damage repair; Radiation

Indexed keywords

CAFFEINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RAT; TUMOR CELL LINE; YOLK SAC TUMOR;

ANIMALS; CAFFEINE; CELL CYCLE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDODERMAL SINUS TUMOR; RADIATION TOLERANCE; RATS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032749627     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00308-0     Document Type: Article

References (34)

1. Peacock J.H., Eady J.J., Edwards S., Hoimers A., Macmillan T.J., Steel G.G. Initial damage or repair as the major determinant of cellular radiosensitivity? Int. J. Radiat. Biol. 56:1989;543-547.
2. Maity A., McKenna W.G., Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31:1994;1-13.
3. Akimoto T., Jinsil S., Hunter R.H., Buchmiller L., Mason K., Milas L. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21WAF1/CIP1 protein. Int. J. Radiat. Oncol. Biol. Phys. 44:(2):1999;413-419.
4. Phillips R.A., Tolmach L.J. Repair of potentially lethal damage in X-irradiated HeLa cells. Radiat. Res. 29:1966;413-432.
5. Little J.B. Repair of sublethal and potentially lethal radiation damage in plateau-phase cultures of human cells. Nature (Lond.). 224:1969;804-806.
6. Weichselbaum R.R. Radioresistant and repair proficient cells may determine radiocurability in human tumors. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;637-639.
7. Weichselbaum R.R., Schmit A., Little J.B. Cellular factors influencing radiocurability of human malignant tumors. Br. J. Cancer. 45:1982;10-16.
8. Boothman D.A., Wang M., Schea R.A., Burrows H.L., Strickfaden S., Owens J. Posttreatment exposure to camptothecin enhances the lethal effect of X-rays on radioresistant human malignant melanoma cells. Int. J. Radiat. Oncol. Biol. Phys. 24:1992;939-948.
9. Teoule R. Radiation-induced DNA damage and its repair. Int. J. Radiat. Biol. 51:1987;573-589.
10. Nozaki M. Biological and histological characteristics of experimental yolk sac tumor developed by fetectomy and their usefulness in radiotherapeutic experiment. J. Jpn. Soc. Ther. Radiat. Oncol. 4:1992;44-53.
11. Mitsuhashi N., Takahashi T., Nozaki M., Matsumoto H., Sakurai H., Takahashi M., Nilbe H. Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis. Jpn. J. Cancer Res. 84:1993;1287-1291.
12. Mitsuhashi N., Takahashi T., Sakurai H., Nozaki M., Akimoto T., Hasegawa M., Saito Y., Matsumoto H., Higuchi K., Maebayashii K., Nilbe H. A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumor cell line. NMT-1: difference of early radiation-induced morphological changes, especially apoptosis. Int. J. Radiat. Biol. 69:1996;329-336.
13. Mitsuhashi N., Ishikawa H., Saito Y., Takahashi T., Sakurai H., Nozaki M., Akimoto T., Hasegawa M., Maebayashi K., Nilbe H. A quantitative study of radiation-induced apoptosis in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Anticancer Res. 17:1997;3605-3608.
14. Nakamoto S., Mitsuhashi N., Takahashi T., Sakurai H., Nlibe H. An interaction of cisplatin and radiation in two rat yolk sac tumor cell lines with different radiosensitivities in vitro. Int. J. Radiat. Biol. 70:1996;747-753.
15. Saito Y., Mitsuhashi N., Takahashi T., Sakurai H., Nozaki M., Ishikawa H., Nasu S., Hayakawa K., Nilbe H. Cytotoxic effect of paclitaxel (taxol) either alone or in combination with irradiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int. J. Radiat. Biol. 73:(2):1998;225-231.
16. Busse P.M., Bose S.K., Jones R.W., Tolmach L.J. The action of caffeine on X-irradiated HeLa cells. II. Synergistic lethality. Radiat. Res. 71:1977;666-677.
17. Lock R.B., Galperia O.V., Feldhoff R.C., Rhodes L.J. Concentration-dependent differences in the mechanism by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res. 54:1994;4933-4939.
18. Powell S.N., Defrank J.S., Connell P., Eogan M., Preffer F., Dombkowski D., Tang W., Friend S. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55:1995;1643-1648.
19. Russell K.J., Wiens L.W., Demers G.W., Galloway D.A., Plon S.E., Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 55:1995;1639-1642.
20. Defrank J.S., Tang W., Powell S.N. p53-Null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res. 56:1996;5365-5368.
21. Narayanan P.K., Rudnick J.M., Walthers E.A., Crissman H.A. Modulation in cell cycle and cyclin B1 expression in irradiated HeLa cells and normal human skin fibroblasts treated with staurosporine and caffeine. Exp. Cell Res. 233:1997;118-127.
22. Maebayashi K., Mitsuhashi N., Takahashi T., Sakurai H., Nilbe H. p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 44:(3):1999;677-682.
23. Ng C.E., Bussey A.M., Raaphorst G.P. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. Int. J. Radiat. Biol. 66:1994;49-57.
24. Radford I.R., Aldridge D.R. Importance of DNA in the induction of apoptosis by ionizing radiation: effect of the scid mutation and DNA ploidy on the radiosensitivities of murine lymphoid cell lines. Int. J. Radiat. Biol. 75:(2):1999;143-153.
25. Su L.N., Little J.B. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated with ras oncogene and/or simian virus 40T-antigen. Radiat. Res. 133:1993;73-79.
26. Fan S., Smith M.L., Rivet D.J., Duha D., Zilan Q., Kohn K.W., Fornance A.J., O'Conner P.M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55:1995;1649-1654.
27. Smith M.L., Chen L.T., Zhan Q., O'Connor P.M., Fomance A.J. Jr. Involvement of the p53 tumor suppresser gene in repair of uv type DNA damage. Oncogene. 10:1995;1053-1059.
28. Scherer S.J., Welter C., Zang K.D., Dooley S. Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2. Biochem. Biophys. Res. Commun. 221:1996;722-728.
29. Pekkola H.K. Servomaa. A. Kiuru, R. Grenmank, Sublethal damage repair capacity in carcinoma cell lines with p53 mutations. Head Neck. 20:(4):1998;298-303.
30. + ionophore nigericin. Int. J. Radiat. Oncol. Biol. Phys. 20:1990;281-285.
31. Selby C., Sancar A. Molecular mechanisms of DNA repair inhibition by caffeine. Proc. Natl. Acad. Sci. USA. 87:1990;3522-3525.
32. Marchese M.J., Zaider M., Hall E.J. Potentially lethal damage repair in human cells. Radiother. Oncol. 9:1987;57-65.
33. Heller D.P., Raaphorst G.P. Inhibition of potentially lethal damage recovery by altered pH, glucose utilization and proliferation in plateau growth phase human glioma cells. Int. J. Radiat. Biol. 66:1994;41-47.
34. Kowk T.T., Sutherland R.M. Repair of potentially lethal radiation damage in human squamous cell carcinoma cells after chronic hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;255-258.